Inspiration Healthcare (IHC) AI Stock Analysis

• Market Cap: £18.83M
• Dividend Yield: N/A
• Average Volume (3M): 73.08K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.15
• Revenue Growth: 1.65%
• EPS Growth: -102.83%
• Country: UK
• Employees: 224
• Sector: Healthcare
• Sector Strength: 40
• Industry: Medical - Devices
• EPS (TTM): -0.13
• Shares Outstanding: 89,663,370
• 10 Day Avg. Volume: 79,692
• 30 Day Avg. Volume: 73,081
• PEG Ratio: 0.06
• Price to Book (P/B): 1.19
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -7.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 42 Neutral
• Price Target: 19.50p ▼(-7.14%Downside)

The overall stock score is primarily impacted by poor financial performance and negative technical analysis, both indicating significant challenges. The valuation further stresses the financial issues with a negative P/E ratio. While the upcoming results announcement is a positive corporate event, it does not outweigh the underlying financial and technical concerns.

Inspiration Healthcare Business Overview & Revenue Model

Company Description

Inspiration Healthcare Group plc is a global provider of medical technology for critical care, operating theatre, and home healthcare applications. Primarily serving the neonatal intensive care sector, the company offers a comprehensive portfolio of products, including advanced respiratory management and patient warming devices. Their mission is to improve patient outcomes across healthcare environments by delivering innovative and high-quality medical solutions.

How the Company Makes Money

Inspiration Healthcare generates revenue through the sale of its medical devices and related services. The company's key revenue streams include direct sales to hospitals and healthcare institutions, as well as distribution agreements with partners in various international markets. The company's products are often sold under long-term contracts and supply agreements, ensuring a steady flow of income. Additionally, Inspiration Healthcare may engage in strategic partnerships and collaborations to expand its product offerings and market reach. Revenue is further supported by after-sales services, including maintenance and technical support, which provide recurring income opportunities.

Inspiration Healthcare Financial Statement Overview

Summary

Inspiration Healthcare faces financial difficulties with declining profitability and increasing leverage. The income statement shows challenges in maintaining margins and growth, while the balance sheet reveals rising debt levels and reduced equity. Cash flow issues further exacerbate concerns, highlighting potential liquidity risks.

Income Statement

Inspiration Healthcare's income statement shows a decline in profitability, with net losses increasing over the past two years. Gross profit margin decreased to 42.82% in 2025 from 47.55% in 2024. Revenue growth has been inconsistent, with a slight increase in 2025 compared to a decrease in 2024. The company is facing significant challenges in maintaining profitability, as evidenced by negative EBIT and EBITDA margins in recent years.

Balance Sheet

The balance sheet reveals a weakening equity position, with stockholders' equity nearly halving from 2024 to 2025. The debt-to-equity ratio increased to 0.90 in 2025, indicating rising leverage. The equity ratio also decreased, showing reduced financial stability. This suggests potential financial risk despite a stable asset base.

Cash Flow

Cash flow analysis indicates deteriorating cash management, with negative operating and free cash flows in 2025. The free cash flow to net income ratio is negative, pointing to challenges in generating cash relative to earnings. The operating cash flow to net income ratio also reflects struggling operations, with significant cash outflows.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	38.25M	37.63M	41.23M	41.05M	36.98M
Gross Profit	16.38M	17.89M	17.63M	20.25M	17.14M
EBITDA	-12.44M	-2.43M	2.76M	6.17M	4.47M
Net Income	-14.97M	-6.03M	272.00K	4.23M	2.81M
Balance Sheet
Total Assets	41.08M	49.01M	54.89M	50.11M	43.23M
Cash, Cash Equivalents and Short-Term Investments	733.00K	609.00K	2.28M	9.25M	10.65M
Total Debt	14.97M	12.83M	13.08M	7.54M	3.17M
Total Liabilities	24.45M	20.05M	19.42M	14.62M	11.66M
Stockholders Equity	16.64M	28.97M	35.47M	35.49M	31.58M
Cash Flow
Free Cash Flow	-3.52M	380.00K	-11.86M	-436.00K	3.79M
Operating Cash Flow	-1.55M	2.01M	-3.52M	3.54M	4.71M
Investing Cash Flow	-1.74M	-2.69M	-8.34M	-3.97M	-14.06M
Financing Cash Flow	3.61M	-1.19M	4.88M	-964.00K	15.53M

Inspiration Healthcare Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 21.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IHC, the sentiment is Neutral. The current price of 21 is below the 20-day moving average (MA) of 22.09, below the 50-day MA of 21.50, and above the 200-day MA of 17.18, indicating a neutral trend. The MACD of -0.36 indicates Positive momentum. The RSI at 42.96 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:IHC.

Inspiration Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SUN	60 Neutral	£6.53M	―	-20.43%	―	-0.57%	-320.00%
Sector *	57 Neutral	£4.72B	6.68	-62.36%	2.70%	34.03%	6.31%
RUA	55 Neutral	£7.14M	1,150.00	0.08%	―	56.29%	―
CREO	55 Neutral	£51.56M	―	-38.49%	―	―	―
IHC	42 Neutral	£18.83M	―	-65.64%	―	1.65%	-102.83%

Inspiration Healthcare Corporate Events

Inspiration Healthcare Publishes Annual Report and Announces AGM Details

Inspiration Healthcare Group plc has published its Annual Report and Accounts for the year ending 31 January 2025, alongside the notice for its upcoming Annual General Meeting (AGM) scheduled for 24 July 2025. The company has shifted to electronic proxy voting, encouraging shareholders to use the Investor Centre app or web platform for appointing proxies, reflecting a move towards digital engagement with stakeholders.

Inspiration Healthcare Announces Board Change as Neil Campbell Steps Down

Inspiration Healthcare Group PLC announced that Neil Campbell, a non-executive director, will not seek re-election at the 2025 Annual General Meeting and will step down from the Board on July 24, 2025. The company does not plan to fill his position immediately but will review the Board’s composition. This change marks a continued transition in leadership following Campbell’s previous role as CEO, signaling a strategic move forward for the company.

Inspiration Healthcare Sees Revenue Growth Amid Strategic Restructuring

Inspiration Healthcare Group plc reported its unaudited preliminary results for the year ended 31 January 2025, highlighting a 1.7% increase in revenue to £38.3 million, despite a decline in gross profit and an operating loss of £14.7 million. The company experienced a challenging first half but saw a strong sales momentum in the second half, driven by a ‘Back to Basics’ strategy and restructuring efforts. Key achievements include a significant order for SLE6000 ventilators and a $6 million contract with an international humanitarian aid organization, setting a positive outlook for FY26 with a strong order book and plans to focus on core strengths and expand in consumables and services.

Inspiration Healthcare to Announce Full-Year Results

Inspiration Healthcare Group plc announced it will release its full-year results for the year ended 31 January 2025 on 28 May 2025. The company will host an analyst briefing and an investor presentation on the same day, allowing existing and potential shareholders to engage with the results. This announcement highlights the company’s commitment to transparency and engagement with stakeholders, potentially impacting its market positioning positively.

Inspiration Healthcare Announces Change in Voting Rights

Inspiration Healthcare Group PLC has announced a change in its voting rights structure due to the acquisition or disposal of shares by Liontrust Investment Partners LLP. The transaction resulted in Liontrust holding 4.616% of the voting rights, down from a previous position of 5.423%. This adjustment in shareholding may influence the company’s decision-making processes and reflects active stakeholder engagement in the company’s governance.

Mennen Medical Increases Stake in Inspiration Healthcare

Inspiration Healthcare Group PLC, a UK-based company, has announced a change in its major holdings. Mennen Medical Ltd., based in Israel, has increased its voting rights in Inspiration Healthcare from 13.008% to 15.016% as of May 14, 2025. This acquisition of voting rights could potentially impact the company’s decision-making processes and influence its strategic direction.